Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $15.6 million.

  • Kewaunee Scientific's Other Operating Expenses rose 6403.66% to $15.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $63.4 million, marking a year-over-year increase of 7258.28%. This contributed to the annual value of $51.1 million for FY2025, which is 5131.18% up from last year.
  • As of Q4 2025, Kewaunee Scientific's Other Operating Expenses stood at $15.6 million, which was up 6403.66% from $16.1 million recorded in Q3 2025.
  • In the past 5 years, Kewaunee Scientific's Other Operating Expenses ranged from a high of $16.1 million in Q1 2025 and a low of $6.0 million during Q1 2021
  • For the 5-year period, Kewaunee Scientific's Other Operating Expenses averaged around $9.3 million, with its median value being $8.1 million (2023).
  • As far as peak fluctuations go, Kewaunee Scientific's Other Operating Expenses plummeted by 1795.92% in 2021, and later soared by 9614.5% in 2025.
  • Kewaunee Scientific's Other Operating Expenses (Quarter) stood at $6.5 million in 2021, then rose by 22.49% to $7.9 million in 2022, then increased by 5.2% to $8.4 million in 2023, then rose by 13.87% to $9.5 million in 2024, then surged by 64.04% to $15.6 million in 2025.
  • Its Other Operating Expenses stands at $15.6 million for Q4 2025, versus $16.1 million for Q3 2025 and $15.5 million for Q2 2025.